FDA approves the first generic for life-saving opioid overdose treatment naloxone that can be carried by untrained individuals
On average, opioids kill more than 130 Americans every day. An effective agent to halt or reverse the effects of an opioid overdose is naloxone, which is available as a nasal spray, an injection, or as an intravenous infusion, and works by temporarily preventing the opioids from attaching to opioid receptors in the brain. On Friday, the FDA approved the first generic version of naloxone nasal spray that can be used to reverse suspected overdose in the community setting, made by Israel’s Teva $TEVA.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.